News

May 2026   From Bank to Bedside is a series of profiles that describe organizations which offer consumers the full range of cellular therapy services, from biobanking to clinical medicine. This month we profile CHA of South Korea. CHA provides an integrated industry-academia-research-hospital ecosystem. The CHA Bio Group is one of the largest medical networks in the Asia-Pacific region, and aims to become the world leader in developing and commercializing new cell therapies.

May 2026   Paraguay has one cord blood bank, the family bank Protectia Paraguay, established in 2015. With Protectia, Paraguay positions itself at the forefront of scientific advancement, ensuring that the biological heritage of its children becomes a key to lifelong well-being.

May 2026   “Maternity Deserts” are parts of the United States where the nearest maternity care is over an hour away. The map of maternity deserts aligns closely with a map of rural poverty. These are places where maternal mortality is higher and birth outcomes are worse. The problems behind maternity deserts are well known, but mothers are still waiting for proposed solutions to be implemented.

Apr 2026   BioLife Solutions has established a Center for Biopreservation Excellence that will provide consulting services to organizations that seek to optimize their cell and gene therapy biopreservation. The establishment of this center reflects the growing recognition that biopreservation methods are critical to clinical and commercial success.

Apr 2026   From Bank to Bedside is a series of profiles that describe organizations which offer consumers the full range of cellular therapy services, from biobanking to clinical medicine. This month we profile MEDEZE in Thailand.

Apr 2026   Preeclampsia and Eclampsia are serious pregnancy complications that are blamed on inadequate attachment of the placenta to the uterus. But is that poor attachment the fault of the placenta, or the fault of the mother, or both?

Mar 2026   From Bank to Bedside is a series of profiles that describe organizations which offer consumers the full range of cellular therapy services, from biobanking to clinical medicine. This month we profile CryoCord in Malaysia.

Mar 2026   The Hepatitis B vaccine (HBV) is given at birth to protect infants against a prevalent virus that causes lifelong illness and is the leading cause of liver cancer.

Feb 2026   Many parents are confused about the revised vaccine schedule published by the CDC. Parents should be reassured that, at least for 2026, their ability to vaccinate their children will not change. The American Academy of Pediatrics (AAP) is encouraging families to continue to follow the standard schedule for childhood vaccines. Insurance providers have guaranteed that they will cover the cost of vaccines through 2026.

Feb 2026   Profile of cord blood banking in Hungary, a country with a strong social network designed to encourage families to have children.